Effect of glycosoaminoglycans on the clinical course of diabetic nephropathy at the stage of microalbuminuria in patients with type 2 diabetes mellitus
Aim. To evaluate clinical efficiency of sulodexide (glycosoaminoglycan) for the treatment of patients with type 2 diabetes mellitus (DM2) and diabeticnephropathy (DN) at the stage of microalbuminuria (MAU). Materials and methods. A total of 30 patients with DM2 and MAU were examined 15 of whom wer...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2010-06-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5671 |
| _version_ | 1826588200595881984 |
|---|---|
| author | Iya Vladimirovna Semenova Lyudmila Alexandrovna Chugunova Alexander Viktorovich Il'in Anna Petrovna Knyazeva Lidia Dmitrievna Chirkova Marina Vladimirovna Shestakova Ivan Ivanovich Dedov |
| author_facet | Iya Vladimirovna Semenova Lyudmila Alexandrovna Chugunova Alexander Viktorovich Il'in Anna Petrovna Knyazeva Lidia Dmitrievna Chirkova Marina Vladimirovna Shestakova Ivan Ivanovich Dedov |
| author_sort | Iya Vladimirovna Semenova |
| collection | DOAJ |
| description | Aim. To evaluate clinical efficiency of sulodexide (glycosoaminoglycan) for the treatment of patients with type 2 diabetes mellitus (DM2) and diabeticnephropathy (DN) at the stage of microalbuminuria (MAU). Materials and methods. A total of 30 patients with DM2 and MAU were examined 15 of whom were given sulodexide (200 mg daily) for 6 months.The following parameters were measured before, 3 and 6 months after the onset of therapy: HbA1c level, biochemical characteristics, highly sensitiveCRB, MAU in morning urine samples, soluble intercellular and vascular cell adhesion molecules-1, blood coagulation and anticoagulation factors(PTI, fibrinogen, thrombin time, coagulation factors VII, VIII, X, Willebrand factor), tissue plasminogen activator, and its inhibitor. Results. Sulodexide produced significant positive effect on albumin excretion in urine. It exerted antithromotic and profibrinolytic action and improvedendothelial function. Taken together, these properties of sulodexide give reason to recommend it as a protector of different vascular segments. Conclusion. Significant positive effect of sulodexide on albumin excretion in urine coupled to its multifactor activity, convenience of therapeutic application,low risk of complications, good tolerability, and safety in aged patients with DM2 permit to consider it as a promising tool for the treatmentof DM2 with MAU. |
| first_indexed | 2024-03-08T15:22:50Z |
| format | Article |
| id | doaj.art-e156276ee1b8436492a7037ca5257bbd |
| institution | Directory Open Access Journal |
| issn | 2072-0351 2072-0378 |
| language | English |
| last_indexed | 2025-03-14T16:37:33Z |
| publishDate | 2010-06-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj.art-e156276ee1b8436492a7037ca5257bbd2025-02-21T09:29:28ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782010-06-01132343910.14341/2072-0351-56715629Effect of glycosoaminoglycans on the clinical course of diabetic nephropathy at the stage of microalbuminuria in patients with type 2 diabetes mellitusIya Vladimirovna Semenova0Lyudmila Alexandrovna Chugunova1Alexander Viktorovich Il'in2Anna Petrovna Knyazeva3Lidia Dmitrievna Chirkova4Marina Vladimirovna Shestakova5Ivan Ivanovich Dedov6Endocrinology Research Centre, MoscowEndocrinology Research Centre, MoscowEndocrinology Research Centre, MoscowEndocrinology Research Centre, MoscowEndocrinology Research Centre, MoscowEndocrinology Research Centre, MoscowEndocrinology Research Centre, MoscowAim. To evaluate clinical efficiency of sulodexide (glycosoaminoglycan) for the treatment of patients with type 2 diabetes mellitus (DM2) and diabeticnephropathy (DN) at the stage of microalbuminuria (MAU). Materials and methods. A total of 30 patients with DM2 and MAU were examined 15 of whom were given sulodexide (200 mg daily) for 6 months.The following parameters were measured before, 3 and 6 months after the onset of therapy: HbA1c level, biochemical characteristics, highly sensitiveCRB, MAU in morning urine samples, soluble intercellular and vascular cell adhesion molecules-1, blood coagulation and anticoagulation factors(PTI, fibrinogen, thrombin time, coagulation factors VII, VIII, X, Willebrand factor), tissue plasminogen activator, and its inhibitor. Results. Sulodexide produced significant positive effect on albumin excretion in urine. It exerted antithromotic and profibrinolytic action and improvedendothelial function. Taken together, these properties of sulodexide give reason to recommend it as a protector of different vascular segments. Conclusion. Significant positive effect of sulodexide on albumin excretion in urine coupled to its multifactor activity, convenience of therapeutic application,low risk of complications, good tolerability, and safety in aged patients with DM2 permit to consider it as a promising tool for the treatmentof DM2 with MAU.https://www.dia-endojournals.ru/jour/article/view/5671dibetes mellitusdiabetic nephropathymicroalbuminuriaheparin sulfatesulodexide |
| spellingShingle | Iya Vladimirovna Semenova Lyudmila Alexandrovna Chugunova Alexander Viktorovich Il'in Anna Petrovna Knyazeva Lidia Dmitrievna Chirkova Marina Vladimirovna Shestakova Ivan Ivanovich Dedov Effect of glycosoaminoglycans on the clinical course of diabetic nephropathy at the stage of microalbuminuria in patients with type 2 diabetes mellitus Сахарный диабет dibetes mellitus diabetic nephropathy microalbuminuria heparin sulfate sulodexide |
| title | Effect of glycosoaminoglycans on the clinical course of diabetic nephropathy at the stage of microalbuminuria in patients with type 2 diabetes mellitus |
| title_full | Effect of glycosoaminoglycans on the clinical course of diabetic nephropathy at the stage of microalbuminuria in patients with type 2 diabetes mellitus |
| title_fullStr | Effect of glycosoaminoglycans on the clinical course of diabetic nephropathy at the stage of microalbuminuria in patients with type 2 diabetes mellitus |
| title_full_unstemmed | Effect of glycosoaminoglycans on the clinical course of diabetic nephropathy at the stage of microalbuminuria in patients with type 2 diabetes mellitus |
| title_short | Effect of glycosoaminoglycans on the clinical course of diabetic nephropathy at the stage of microalbuminuria in patients with type 2 diabetes mellitus |
| title_sort | effect of glycosoaminoglycans on the clinical course of diabetic nephropathy at the stage of microalbuminuria in patients with type 2 diabetes mellitus |
| topic | dibetes mellitus diabetic nephropathy microalbuminuria heparin sulfate sulodexide |
| url | https://www.dia-endojournals.ru/jour/article/view/5671 |
| work_keys_str_mv | AT iyavladimirovnasemenova effectofglycosoaminoglycansontheclinicalcourseofdiabeticnephropathyatthestageofmicroalbuminuriainpatientswithtype2diabetesmellitus AT lyudmilaalexandrovnachugunova effectofglycosoaminoglycansontheclinicalcourseofdiabeticnephropathyatthestageofmicroalbuminuriainpatientswithtype2diabetesmellitus AT alexanderviktorovichilin effectofglycosoaminoglycansontheclinicalcourseofdiabeticnephropathyatthestageofmicroalbuminuriainpatientswithtype2diabetesmellitus AT annapetrovnaknyazeva effectofglycosoaminoglycansontheclinicalcourseofdiabeticnephropathyatthestageofmicroalbuminuriainpatientswithtype2diabetesmellitus AT lidiadmitrievnachirkova effectofglycosoaminoglycansontheclinicalcourseofdiabeticnephropathyatthestageofmicroalbuminuriainpatientswithtype2diabetesmellitus AT marinavladimirovnashestakova effectofglycosoaminoglycansontheclinicalcourseofdiabeticnephropathyatthestageofmicroalbuminuriainpatientswithtype2diabetesmellitus AT ivanivanovichdedov effectofglycosoaminoglycansontheclinicalcourseofdiabeticnephropathyatthestageofmicroalbuminuriainpatientswithtype2diabetesmellitus |